Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022800305> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W3022800305 abstract "Thromboembolism prevention is a crucial factor determining both the natural outcome and outcome of intervention of stenotic atherosclerotic carotid artery pathology. Roughly 80% of all natural course cerebral ischemic events are caused by thromboembolism, versus 20% due to hemodynamic insufficiency. The risk of periprocedural cerebral (micro-) thromboembolization during carotid revascularization is considered to be even higher, with a higher rate in carotid artery stenting (CAS) as compared to carotid endarterectomy (CEA). Guidelines on CEA and CAS are unanimous in advising perioperative continuation of antiplatelet therapy (APT) for all patients to prevent thromboembolization without specification of the type of APT. Recommendations on dual antiplatelet (DAPT) therapy are inconsistent. Bridging vitamin K antagonists (VKA) perioperative with unfractionated heparin (UFH) or low-molecular weight heparins (LMWHs) might not be necessary for CAS, while CEA-specific data is lacking. No data are available on the use and position of direct-acting oral anticoagulants (DOACs) for CEA or CAS. Guidelines on treatment of carotid artery disease currently do not provide information on perioperative heparinization. There are several monitoring tools to detect perioperative micro-embolic signals during intervention or new cerebral white matter lesions following CEA or CAS. Transcranial Doppler ultrasonography (TDU) and diffusion weighed imaging (DWI) might be used to assess these (secondary) outcome measurements. The use of platelet function testing (PFT) to tailor APT might contribute to finding the therapeutic place of stronger APT and new APT regimen. Periprocedural antiplatelet and anticoagulation therapy for carotid revascularization still lacks solid evidence and guidelines do not yet cover the full spectrum of anticoagulants and procedural steps. This review aims to cover and discuss the full spectrum of available antiplatelet and anticoagulant drugs and therapies available for thromboembolism prevention during all crucial steps of revascularization and specify the need to know topics to be addressed in future research." @default.
- W3022800305 created "2020-05-13" @default.
- W3022800305 creator A5020097116 @default.
- W3022800305 creator A5054039215 @default.
- W3022800305 date "2017-02-01" @default.
- W3022800305 modified "2023-09-27" @default.
- W3022800305 title "Evidence for periprocedural antiplatelet therapy, heparinization and bridging of coumarin therapy in carotid revascularization" @default.
- W3022800305 doi "https://doi.org/10.23736/s0021-9509.16.09851-7" @default.
- W3022800305 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28045242" @default.
- W3022800305 hasPublicationYear "2017" @default.
- W3022800305 type Work @default.
- W3022800305 sameAs 3022800305 @default.
- W3022800305 citedByCount "4" @default.
- W3022800305 countsByYear W30228003052019 @default.
- W3022800305 countsByYear W30228003052020 @default.
- W3022800305 countsByYear W30228003052021 @default.
- W3022800305 countsByYear W30228003052022 @default.
- W3022800305 crossrefType "journal-article" @default.
- W3022800305 hasAuthorship W3022800305A5020097116 @default.
- W3022800305 hasAuthorship W3022800305A5054039215 @default.
- W3022800305 hasConcept C126322002 @default.
- W3022800305 hasConcept C141071460 @default.
- W3022800305 hasConcept C164705383 @default.
- W3022800305 hasConcept C177713679 @default.
- W3022800305 hasConcept C191616109 @default.
- W3022800305 hasConcept C2776184368 @default.
- W3022800305 hasConcept C2777557582 @default.
- W3022800305 hasConcept C2779169563 @default.
- W3022800305 hasConcept C2779464278 @default.
- W3022800305 hasConcept C2781068581 @default.
- W3022800305 hasConcept C2987047532 @default.
- W3022800305 hasConcept C31174226 @default.
- W3022800305 hasConcept C500558357 @default.
- W3022800305 hasConcept C71924100 @default.
- W3022800305 hasConceptScore W3022800305C126322002 @default.
- W3022800305 hasConceptScore W3022800305C141071460 @default.
- W3022800305 hasConceptScore W3022800305C164705383 @default.
- W3022800305 hasConceptScore W3022800305C177713679 @default.
- W3022800305 hasConceptScore W3022800305C191616109 @default.
- W3022800305 hasConceptScore W3022800305C2776184368 @default.
- W3022800305 hasConceptScore W3022800305C2777557582 @default.
- W3022800305 hasConceptScore W3022800305C2779169563 @default.
- W3022800305 hasConceptScore W3022800305C2779464278 @default.
- W3022800305 hasConceptScore W3022800305C2781068581 @default.
- W3022800305 hasConceptScore W3022800305C2987047532 @default.
- W3022800305 hasConceptScore W3022800305C31174226 @default.
- W3022800305 hasConceptScore W3022800305C500558357 @default.
- W3022800305 hasConceptScore W3022800305C71924100 @default.
- W3022800305 hasLocation W30228003051 @default.
- W3022800305 hasLocation W30228003052 @default.
- W3022800305 hasOpenAccess W3022800305 @default.
- W3022800305 hasPrimaryLocation W30228003051 @default.
- W3022800305 hasRelatedWork W2001992909 @default.
- W3022800305 hasRelatedWork W2002146606 @default.
- W3022800305 hasRelatedWork W2052914743 @default.
- W3022800305 hasRelatedWork W2094962007 @default.
- W3022800305 hasRelatedWork W2097796400 @default.
- W3022800305 hasRelatedWork W2105862563 @default.
- W3022800305 hasRelatedWork W2130243920 @default.
- W3022800305 hasRelatedWork W2472439534 @default.
- W3022800305 hasRelatedWork W4251486296 @default.
- W3022800305 hasRelatedWork W4280523441 @default.
- W3022800305 isParatext "false" @default.
- W3022800305 isRetracted "false" @default.
- W3022800305 magId "3022800305" @default.
- W3022800305 workType "article" @default.